Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver | 20 | 2020 | 492 | 2.090 |
Why?
|
| Liver Regeneration | 7 | 2015 | 23 | 0.840 |
Why?
|
| Stem Cells | 6 | 2018 | 321 | 0.770 |
Why?
|
| Hepatocytes | 6 | 2015 | 80 | 0.760 |
Why?
|
| Organoids | 7 | 2020 | 99 | 0.670 |
Why?
|
| Tissue Engineering | 8 | 2018 | 695 | 0.660 |
Why?
|
| Cell Differentiation | 4 | 2018 | 461 | 0.630 |
Why?
|
| Hepatic Stellate Cells | 2 | 2015 | 4 | 0.540 |
Why?
|
| Hyaluronic Acid | 2 | 2016 | 51 | 0.490 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2009 | 65 | 0.480 |
Why?
|
| Tissue Scaffolds | 7 | 2016 | 431 | 0.470 |
Why?
|
| Mechanical Phenomena | 1 | 2015 | 29 | 0.460 |
Why?
|
| Extracellular Matrix | 3 | 2016 | 256 | 0.450 |
Why?
|
| Liver Neoplasms | 3 | 2009 | 164 | 0.450 |
Why?
|
| Stem Cell Transplantation | 4 | 2012 | 221 | 0.440 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2015 | 73 | 0.430 |
Why?
|
| Animals | 21 | 2019 | 8199 | 0.410 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2015 | 165 | 0.400 |
Why?
|
| Somatostatin | 2 | 2010 | 11 | 0.390 |
Why?
|
| Cell Proliferation | 8 | 2019 | 603 | 0.360 |
Why?
|
| Connective Tissue Growth Factor | 3 | 2010 | 7 | 0.360 |
Why?
|
| Cytokines | 2 | 2019 | 237 | 0.330 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 22 | 0.330 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 42 | 0.310 |
Why?
|
| Rats | 11 | 2015 | 1895 | 0.310 |
Why?
|
| Regenerative Medicine | 4 | 2018 | 217 | 0.290 |
Why?
|
| Lab-On-A-Chip Devices | 3 | 2020 | 29 | 0.290 |
Why?
|
| Cell Separation | 1 | 2009 | 89 | 0.280 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2017 | 70 | 0.280 |
Why?
|
| Biosensing Techniques | 2 | 2017 | 24 | 0.260 |
Why?
|
| Aflatoxin B1 | 2 | 2009 | 3 | 0.230 |
Why?
|
| Rats, Inbred F344 | 9 | 2013 | 151 | 0.220 |
Why?
|
| Hepatectomy | 8 | 2010 | 57 | 0.220 |
Why?
|
| DNA Adducts | 1 | 2004 | 15 | 0.210 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 26 | 0.210 |
Why?
|
| Neoplastic Stem Cells | 1 | 2005 | 96 | 0.210 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 146 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 258 | 0.200 |
Why?
|
| Cell Survival | 4 | 2020 | 288 | 0.190 |
Why?
|
| Myocardium | 3 | 2020 | 184 | 0.180 |
Why?
|
| Humans | 19 | 2020 | 32284 | 0.170 |
Why?
|
| Liver Diseases | 3 | 2010 | 72 | 0.160 |
Why?
|
| Hydrogels | 3 | 2016 | 125 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2019 | 89 | 0.160 |
Why?
|
| Automation | 2 | 2018 | 28 | 0.160 |
Why?
|
| Liver Transplantation | 4 | 2014 | 185 | 0.160 |
Why?
|
| Myocytes, Cardiac | 2 | 2017 | 90 | 0.160 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 2019 | 2 | 0.150 |
Why?
|
| Receptors, Peptide | 1 | 2019 | 8 | 0.150 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 38 | 0.150 |
Why?
|
| Perfusion | 2 | 2010 | 75 | 0.150 |
Why?
|
| Cell Movement | 3 | 2009 | 167 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 79 | 0.150 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 170 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 478 | 0.150 |
Why?
|
| Urinary Tract | 1 | 2018 | 31 | 0.140 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 2009 | 23 | 0.140 |
Why?
|
| Bioreactors | 1 | 2018 | 58 | 0.140 |
Why?
|
| Urothelium | 1 | 2018 | 64 | 0.140 |
Why?
|
| Urine | 1 | 2018 | 69 | 0.140 |
Why?
|
| Biocompatible Materials | 2 | 2018 | 240 | 0.130 |
Why?
|
| Mice | 5 | 2019 | 2571 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2019 | 727 | 0.130 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 34 | 0.130 |
Why?
|
| Bioengineering | 2 | 2014 | 77 | 0.130 |
Why?
|
| Carcinogens | 5 | 2010 | 36 | 0.120 |
Why?
|
| Liver, Artificial | 1 | 2016 | 5 | 0.120 |
Why?
|
| Toxicity Tests | 1 | 2016 | 12 | 0.120 |
Why?
|
| Biological Assay | 1 | 2016 | 18 | 0.120 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2015 | 12 | 0.120 |
Why?
|
| Solubility | 1 | 2015 | 39 | 0.120 |
Why?
|
| Glycosaminoglycans | 1 | 2015 | 23 | 0.120 |
Why?
|
| Cytoplasm | 1 | 2015 | 29 | 0.120 |
Why?
|
| Protein Kinases | 1 | 2015 | 34 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2015 | 100 | 0.110 |
Why?
|
| Cell Transplantation | 1 | 2015 | 65 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2016 | 193 | 0.110 |
Why?
|
| 2-Acetylaminofluorene | 6 | 2010 | 7 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 155 | 0.100 |
Why?
|
| Spheroids, Cellular | 3 | 2020 | 36 | 0.100 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2012 | 1 | 0.090 |
Why?
|
| Glucagon | 1 | 2012 | 5 | 0.090 |
Why?
|
| Heart | 3 | 2017 | 177 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2012 | 50 | 0.090 |
Why?
|
| Islets of Langerhans | 1 | 2012 | 73 | 0.090 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 2 | 2009 | 9 | 0.080 |
Why?
|
| Proteins | 1 | 2012 | 149 | 0.080 |
Why?
|
| Models, Animal | 2 | 2008 | 188 | 0.080 |
Why?
|
| Sus scrofa | 3 | 2015 | 47 | 0.080 |
Why?
|
| Wnt1 Protein | 1 | 2010 | 3 | 0.080 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2009 | 1 | 0.080 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2009 | 4 | 0.080 |
Why?
|
| Cholangiocarcinoma | 1 | 2009 | 12 | 0.070 |
Why?
|
| Hypoglycemia | 1 | 2009 | 43 | 0.070 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2009 | 13 | 0.070 |
Why?
|
| Immunomagnetic Separation | 1 | 2009 | 4 | 0.070 |
Why?
|
| Collagenases | 1 | 2009 | 9 | 0.070 |
Why?
|
| Gravitation | 1 | 2009 | 5 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2009 | 184 | 0.070 |
Why?
|
| Bile Ducts | 1 | 2008 | 19 | 0.070 |
Why?
|
| Metabolic Diseases | 1 | 2008 | 17 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2009 | 136 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2009 | 1083 | 0.070 |
Why?
|
| Microfluidics | 2 | 2017 | 18 | 0.070 |
Why?
|
| Bone Marrow Cells | 1 | 2007 | 114 | 0.060 |
Why?
|
| Receptors, Somatostatin | 1 | 2006 | 5 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2020 | 839 | 0.060 |
Why?
|
| Equipment Design | 2 | 2017 | 178 | 0.060 |
Why?
|
| Polyethylene Glycols | 2 | 2016 | 63 | 0.060 |
Why?
|
| Swine | 2 | 2018 | 228 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 8 | 0.060 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2005 | 6 | 0.060 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 73 | 0.050 |
Why?
|
| Male | 9 | 2018 | 19443 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2006 | 243 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 100 | 0.050 |
Why?
|
| Models, Biological | 2 | 2017 | 408 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 315 | 0.050 |
Why?
|
| Phenotype | 1 | 2005 | 622 | 0.050 |
Why?
|
| RNA Interference | 2 | 2012 | 78 | 0.040 |
Why?
|
| alpha-Fetoproteins | 2 | 2010 | 10 | 0.040 |
Why?
|
| Astemizole | 1 | 2020 | 5 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2019 | 18 | 0.040 |
Why?
|
| Organ Size | 2 | 2010 | 221 | 0.040 |
Why?
|
| In Situ Hybridization | 2 | 2012 | 40 | 0.040 |
Why?
|
| Cell Shape | 1 | 2018 | 28 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2018 | 19 | 0.040 |
Why?
|
| Tight Junctions | 1 | 2018 | 11 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 257 | 0.040 |
Why?
|
| Industry | 1 | 2018 | 15 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 729 | 0.030 |
Why?
|
| Culture Media | 1 | 2018 | 48 | 0.030 |
Why?
|
| Quality Control | 1 | 2018 | 43 | 0.030 |
Why?
|
| Heart Rate | 1 | 2020 | 362 | 0.030 |
Why?
|
| Collagen | 1 | 2018 | 229 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 2 | 2008 | 68 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2017 | 38 | 0.030 |
Why?
|
| Microfibrils | 1 | 2016 | 3 | 0.030 |
Why?
|
| Gelatin | 1 | 2016 | 29 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2016 | 24 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 44 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2016 | 44 | 0.030 |
Why?
|
| Lung | 1 | 2017 | 263 | 0.030 |
Why?
|
| Tissue Survival | 1 | 2015 | 13 | 0.030 |
Why?
|
| Solutions | 1 | 2015 | 40 | 0.030 |
Why?
|
| Urea | 1 | 2015 | 38 | 0.030 |
Why?
|
| Albumins | 1 | 2015 | 42 | 0.030 |
Why?
|
| Rheology | 1 | 2015 | 35 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 339 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2014 | 37 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2014 | 66 | 0.030 |
Why?
|
| Female | 4 | 2014 | 19947 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 109 | 0.020 |
Why?
|
| Pancreatic Diseases | 1 | 2012 | 21 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 26 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 2012 | 17 | 0.020 |
Why?
|
| Liver Failure | 1 | 2012 | 21 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 49 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 246 | 0.020 |
Why?
|
| Organ Transplantation | 1 | 2012 | 67 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 160 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 346 | 0.020 |
Why?
|
| Frizzled Receptors | 1 | 2010 | 5 | 0.020 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2010 | 6 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2010 | 27 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 545 | 0.020 |
Why?
|
| beta Catenin | 1 | 2010 | 38 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 63 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 267 | 0.020 |
Why?
|
| Apoptosis | 1 | 2012 | 375 | 0.020 |
Why?
|
| Insulin | 1 | 2012 | 359 | 0.020 |
Why?
|
| Liver Glycogen | 1 | 2009 | 3 | 0.020 |
Why?
|
| Animals, Suckling | 1 | 2009 | 4 | 0.020 |
Why?
|
| Weaning | 1 | 2009 | 6 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2009 | 7 | 0.020 |
Why?
|
| Animal Husbandry | 1 | 2009 | 8 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2009 | 14 | 0.020 |
Why?
|
| Reproduction | 1 | 2009 | 17 | 0.020 |
Why?
|
| Cysteine | 1 | 2010 | 145 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 19 | 0.020 |
Why?
|
| Fibrosis | 1 | 2009 | 126 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 222 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 454 | 0.020 |
Why?
|
| Body Weight | 1 | 2009 | 323 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2007 | 5 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2007 | 5 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 68 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2006 | 20 | 0.020 |
Why?
|
| Antibodies | 1 | 2006 | 56 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 9259 | 0.010 |
Why?
|
| Iloprost | 1 | 2005 | 1 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2005 | 8 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 27 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 521 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 717 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2005 | 62 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 520 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 186 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 11853 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 299 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 2205 | 0.010 |
Why?
|